Skip to content
Saturday, November 7, 2026
Maple Observer

Giving Stem Cells During Pregnancy to Babies with Neural Tube Defect Enhances Life Outcomes, Trial Finds

A pioneering clinical study has found that administering stem cells to fetuses affected by spina bifida while undergoing fetal surgery can be a "significant breakthrough" in managing prenatal disorders.

Trial Details and Safety

The US-based trial examined six unborn babies with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells to the surface of the infant's spine during the repair procedure.

Significantly, the cell therapy demonstrated a favorable safety profile. Doctors verified that the treatment did not lead to tumors, hinder surgical recovery, or block the correction of associated brain abnormalities.

Promising Outcomes

Post-birth MRI scans showed a complete reversal of brainstem displacement in every participant. This favorable anatomical change is closely linked to better mobility and function.

"If it makes more children to achieve ambulation who previously could not, it may emerge as the conventional approach," commented the principal investigator. "The outcomes appear super exciting and create a pathway toward lots of potential new treatments."

Future Implications and Hope

Experts not involved in the trial have suggested that additional validation of these noted improvements could herald a "new era" in in-utero treatment. The prospect of enhancing neurological damage occurring during fetal development is considered a revolutionary objective.

Especially significant would be advancements for continence and digestive health, which are typical difficulties for those diagnosed with this defect.

Looking Ahead

While this initial trial focused on a handful of cases, its confirmed tolerability and hopeful trends create a solid basis for larger, more comprehensive studies. The addition of cellular treatment with proven prenatal surgical methods holds considerable promise for improving the prognosis for future generations with spina bifida.

About the author

Jane Stewart

A botanist with over 15 years of experience specializing in temperate forest ecosystems and sustainable arboriculture practices.

Maple Observer

Type to search articles.